• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Medicare Advantage Enrollment Rose, Despite ACA, Kaiser Report Shows

Article

A recent report from the Kaiser Family Foundation found that inital concern over Medicare Advantage enrollment decreasing due to healthcare reform is unfounded. Rates of enrollment have actually increased:

Despite concern that the healthcare reform law would dampen Medicare Advantage enrollment, the opposite has happened so far, according the Kaiser Family Foundation.

Between the beginning of 2012 and March 2013, 1 million more beneficiaries enrolled in the program, a nearly 10% year-over-year increase, bringing total Medicare Advantage enrollment to 14.4 million this year, according to a new report by Kaiser and Mathematica Policy Research. Since 2009, enrollment in MA had grown 30%.

Under the Patient Protection and Affordable Care Act, Medicare payments to Advantage plans last year began to depend on the correlation between their bids and fee-for-service costs in individual counties, though payments to plans can also increase based on quality of service provided. While 2011 payments were held at 2010 levels, the maximum amount a plan could be paid by Medicare began to go down in 2012.

The Kaiser and Mathematic researchers found that the changes didn't negatively affect enrollment in Advantage plans. “There is little evidence of an adverse effect on enrollment in low- versus high-cost counties,” the study says.

Read the full story here: http://bit.ly/19ZwwHo

Source: Modern Healthcare

Related Videos
Margaret Krackeler, MD
Margaret Krackeler, MD
Philip Mease, MD
A new study finds law enforcement presence in emergency departments may disrupt care. Lead author Prashasti Bhatnagar discusses policy and training solutions.
Jennifer Snow, MPA, NAMI
Jennifer Snow, MPA, NAMI
Most employees are unprepared to shop for coverage on their own, underscoring the need for stronger decision tools and consumer protections.
Experts warn that ICHRAs could either stabilize or destabilize the individual market, depending on which workers employers shift into these plans.
Aleata Postell, SVP of pharmacy business development, CenterWell Pharmacy
Where patients live may shape outcomes in hypertrophic cardiomyopathy, with SDOH linked to higher risks of heart failure and arrhythmias.
Related Content
© 2026 MJH Life Sciences
AJMC®
All rights reserved.